Relipoietin 4000iu 0.4ml PFS Injection

Relipoietin 4000iu 0.4ml PFS Injection contains Recombinant Human Erythropoietin Alfa, an erythropoiesis-stimulating agent used to treat anemia caused by chronic kidney disease, chemotherapy, or HIV infection.

Benefits

This injection helps boost the body's red blood cell production, which can reduce the need for frequent blood transfusions in anemic patients. It also supports patient comfort and energy levels during treatment, improving tolerance to chemotherapy and reducing fatigue in those with chronic kidney disease.

Uses and Indications

• Anemia caused by chronic kidney disease (CKD) in adults and children, including those undergoing dialysis.
• Anemia resulting from cancer chemotherapy, particularly in patients with non-myeloid malignancies.
• Anemia associated with HIV infection treatment, such as with zidovudine.
• Reduction of the need for red blood cell transfusions in patients at high risk for blood loss due to planned, noncardiac, nonvascular surgery.

The Relipoietin 4000iu 0.4ml PFS Injection contains:

• Recombinant Human Erythropoietin Alfa 4000IU/0.4ml (active ingredient).

Dosage and Administration

1. Relipoietin 4000iu 0.4ml PFS Injection is administered by a doctor or nurse, either intravenously (into the vein) or subcutaneously (under the skin).
2. The dosage and frequency, typically one to three times per week or once/bi-weekly, are determined by the prescribing doctor based on the patient's condition, body weight, hemoglobin levels, and response to treatment.
3. For subcutaneous injections, common sites include the upper arms, abdomen, front of the thighs, or upper outer buttocks; it is important to rotate injection sites.
4. Iron supplements may be given before and during treatment to enhance its effectiveness.

Storage and Disposal

• Store Relipoietin 4000iu 0.4ml PFS Injection in a refrigerator between 2°C and 8°C.
• Do not freeze the injection, as freezing can damage the protein structure.
• Protect the injection from light and keep it in its original packaging until use.
• Keep out of reach of children and pets.
• Any unused portion must be discarded immediately after administration.

Precautions and Safety

• Relipoietin 4000iu 0.4ml PFS Injection is not recommended for patients who have recently experienced a heart attack or stroke.
• It is not suitable for individuals with severe, uncontrolled high blood pressure or a condition called pure red cell aplasia.
• Inform your doctor if you are pregnant or breastfeeding, or if you have any liver, kidney, or heart problems, diabetes, obesity, breast cancer, head and neck cancer, a history of fits/epilepsy, previous blood clots, or if you are undergoing dialysis or surgery.
• Regular monitoring of blood pressure and iron levels is crucial during treatment.
• Avoid driving or operating machinery if you experience fits or seizures after taking this medicine.
• Do not exceed the prescribed dose, as an overdose can lead to fits and high blood pressure.
• Inform your doctor about all medicines, supplements, or herbals you are currently taking to avoid potential interactions.

Side Effects and Risks

• Common side effects may include diarrhea, nausea, vomiting, fever, stuffy nose, sore throat, headache, muscle cramps, pain, redness, or swelling at the injection site, fatigue, dizziness, and joint pain.
• More serious side effects can include high blood pressure (hypertension), blood clots (thromboembolic events), stroke, allergic reactions (such as skin rash, swelling of the face and lips, or red spots), and seizures/fits.
• Some studies have indicated an unexplained statistically significant excess mortality, cardiovascular events, and tumor progression or recurrence in patients receiving recombinant human erythropoietin for certain cancers.

Disclaimer

Use this medicine only under the prescription and guidance of a qualified doctor or pharmacist.